Beam Therapeutics Inc.
BEAM
NASDAQ
16.36
USD-0.49(-2.91%)
As of today
Beam Therapeutics Inc. Ratios
| Dividend Yield (TTM) | 0.00 |
| Dividend Yield Percentage (TTM) | 0.00 |
| Price-to-Earnings Ratio (TTM) | -4.19 |
| Price/Earnings-to-Growth Ratio (TTM) | -1.75 |
| Payout Ratio (TTM) | 0.00 |
| Current Ratio (TTM) | 6.75 |
| Quick Ratio (TTM) | 6.75 |
| Cash Ratio (TTM) | 1.62 |
| Days of Sales Outstanding (TTM) | 0.00 |
| Days of Inventory Outstanding (TTM) | 0.00 |
| Operating Cycle (TTM) | 0.00 |
| Days of Payables Outstanding (TTM) | 695.73 |
| Cash Conversion Cycle (TTM) | -695.73 |
| Gross Profit Margin (TTM) | 0.04 |
| Operating Profit Margin (TTM) | -7.40 |
| Pre-tax Profit Margin (TTM) | -6.61 |
| Net Profit Margin (TTM) | -6.61 |
| Effective Tax Rate (TTM) | 0.00 |
| Return on Assets (TTM) | -0.29 |
| Return on Equity (TTM) | -0.43 |
| Return on Capital Employed (TTM) | -0.37 |
| Net Income per Earnings Before Tax (TTM) | 1.00 |
| Earnings Before Tax per EBIT (TTM) | 0.89 |
| EBIT per Revenue (TTM) | -7.40 |
| Debt Ratio (TTM) | 0.11 |
| Debt-to-Equity Ratio (TTM) | 0.15 |
| Long-Term Debt to Capitalization (TTM) | 0.12 |
| Total Debt to Capitalization (TTM) | 0.13 |
| Interest Coverage Ratio (TTM) | -36.18 |
| Cash Flow to Debt Ratio (TTM) | -2.23 |
| Equity Multiplier (TTM) | 1.33 |
| Receivables Turnover Ratio (TTM) | 0.00 |
| Payables Turnover Ratio (TTM) | 0.52 |
| Inventory Turnover Ratio (TTM) | 0.00 |
| Fixed Asset Turnover Ratio (TTM) | 0.29 |
| Asset Turnover Ratio (TTM) | 0.04 |
| Operating Cash Flow per Share (TTM) | -3.38 |
| Free Cash Flow per Share (TTM) | -3.49 |
| Cash per Share (TTM) | 11.28 |
| Operating Cash Flow to Sales Ratio (TTM) | -5.72 |
| Free Cash Flow to Operating Cash Flow Ratio (TTM) | 1.03 |
| Cash Flow Coverage Ratio (TTM) | -2.23 |
| Short-Term Coverage Ratio (TTM) | -26.63 |
| Capital Expenditure Coverage Ratio (TTM) | -32.08 |
| Dividend Paid & CapEx Coverage Ratio (TTM) | -32.08 |
| Price-to-Book Value Ratio (TTM) | 1.59 |
| Price-to-Book Ratio (TTM) | 1.59 |
| Price-to-Sales Ratio (TTM) | 27.46 |
| Price-to-Earnings Ratio (TTM) | -4.19 |
| Price-to-Free Cash Flow Ratio (TTM) | -4.65 |
| Price-to-Operating Cash Flow Ratio (TTM) | -4.84 |
| Price-to-Cash Flow Ratio (TTM) | -4.84 |
| Price/Earnings-to-Growth Ratio (TTM) | -1.75 |
| Price-to-Sales Ratio (TTM) | 27.46 |
| Enterprise Value Multiple (TTM) | -3.85 |
| Price-to-Fair Value Ratio (TTM) | 1.59 |
| Dividend per Share (TTM) | 0.00 |